Science and Research

The Science and Research team at Arkuda Therapeutics drives the discovery and development of novel therapies targeting progranulin and lysosomal pathways to combat neurodegenerative diseases. Comprised of specialists in neurobiology, medicinal chemistry, pharmacology, and toxicology, the team conducts cutting-edge research, preclinical studies, and drug development to advance Arkuda's pipeline of therapeutic candidates.